Published September 10, 2025 | Version v1
Other Open

What are the benefits and risks of using SGLT2 inhibitors in elderly patients with heart failure and type 2 diabetes?

Authors/Creators

  • 1. Tripdatabase

Description

SGLT2 inhibitors provide significant cardiovascular and renal benefits for elderly patients with type 2 diabetes and heart failure, balanced against the risks of genitourinary infections and potential for ketoacidosis, particularly in frailty and comorbidity contexts.

Files

a4874d53-a26c-4d84-835a-6fe423a2ef29.pdf

Files (18.5 kB)

Name Size
md5:ad8693f398bcc6dac96d67f2a2948c05
18.5 kB Preview Download

Additional details

Related works

Is identical to
https://www.tripdatabase.com/ask/benefits-risks-sglt2-inhibitors-elderly-heart-failure-type-2-diabetes-a4874d53-a26c-4d84-835a-6fe423a2ef29 (URL)